Maestri, C. A., Nisihara, R., Mendes, H. W., Jensenius, J., Thiel, S., Messias-Reason, I., & de Carvalho, N. S. (2018). MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression. Front Immunol.
シカゴスタイル引用形Maestri, Carlos Afonso, Renato Nisihara, Hellen Weinschutz Mendes, Jens Jensenius, Stephen Thiel, Iara Messias-Reason, , Newton Sérgio de Carvalho. "MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression." Front Immunol 2018.
MLA引用形式Maestri, Carlos Afonso, et al. "MASP-1 and MASP-2 Serum Levels Are Associated With Worse Prognostic in Cervical Cancer Progression." Front Immunol 2018.
警告: この引用は必ずしも正確ではありません.